Status | Study |
Active, not recruiting |
Study Name: Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer Condition: Recurrent Salivary Gland Cancer Stage IVA Salivary Gland Cancer Date: 2012-06-05 Interventions: Drug: eribulin mesylate Given IV Other Names: |
Recruiting |
Study Name: Activity of Sorafenib in Salivary Gland Cancer Condition: Salivary Gland Cancer Date: 2012-04-06 Interventions: Drug: Sorafenib 400 mg twice daily, on a continuous basis (each morning and evening), in 4 week cycles |
Completed |
Study Name: A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors Condition: Malignant Salivary Gland Tumors Date: 2011-12-07 Interventions: Drug: Cisplatin: 40 mg/m2 weekly during radiation |
Recruiting |
Study Name: Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery Condition: Head and Neck Cancer Date: 2010-10-12 Interventions: Drug: cisplatin Given IV |
Withdrawn |
Study Name: Trial of Radiotherapy and Panitumumab in Salivary Gland Malignancies Condition: Adenoma, Pleomorphic Mixed Salivary Gland Tumor Date: 2009-09-23 Interventions: Radiation: Radiation Radiation |
Active, not recruiting |
Study Name: Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Condition: High-grade Salivary Gland Mucoepidermoid Carcinoma Low-grade Salivary Gland Mucoepidermoid C Date: 2009-03-10 Interventions: Drug: dasatinib Given orally |
Recruiting |
Study Name: Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample Condition: Breast Cancer Stomach Neoplasms Sali Date: 2007-12-04 |
Completed |
Study Name: Iressa Study in Patients With Salivary Gland Cancer Condition: Salivary Gland Cancer Date: 2007-07-26 Interventions: Drug: Gefitinib 250 mg by mouth once a day, every day, at about same time in morning. |
Completed |
Study Name: Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers Condition: High-grade Salivary Gland Carcinoma High-grade Salivary Gland Mucoepidermoid Carcinoma Date: 2004-11-05 Interventions: Drug: lapatinib ditosylate Giv |
Completed |
Study Name: Cisplatin or Carboplatin Combined With Gemcitabine in Treating Patients With Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor Condition: Head and Neck Cancer Date: 2004-03-08 Interventions: Drug: carboplatin Drug: cisplatin |